RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +14.2% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 11.24M | +22.8% | $207.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.21M | +1.2% | $59.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.21M | +1.2% | $59.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 2.15M | -23.8% | $39.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 2.15M | -23.8% | $39.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.62M | +0.9% | $29.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 1.62M | +0.9% | $29.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Millennium Management ✦ | 1.20M | +1041.7% | $22.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (passief) | 159.09K | +357.8% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 48.10K | Nieuw | $888,331 | 0.0% | New | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 21.82K | -5.5% | $402,942 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 18.91K | Nieuw | $349,231 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 18.91K | Nieuw | $349,231 | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 10.10K | -48.4% | $186,547 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $888,331 | 0.0% |
| AQR Capital Management | $349,231 | 0.0% |
| AQR Capital Management | $349,231 | 0.0% |
Verlaten
| Adage Capital Partners | $4.31M | was 0.0% |
| Renaissance Technologies | $2.14M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 195 houders, 96.37M aandelen, $341.40M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.29K aand · $7,753
Officer · 631 aand · $2,133
Officer · 4.70K aand · $16,449
Officer · 36.66K aand · $128,266
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie